To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Tricholoma
The genus Tricholoma contains a large number of fairly fleshy white-spored gilled mushrooms which are found worldwide generally growing in woodland. These are ectomycorrhizal fungi, existing in a symbiotic relationship with various species of coniferous or broad-leaved trees. The generic name derives from the Greek τριχος "hair" and λομα "fringe", although only a few species (such as T. vaccinum) have shaggy caps which fit this description. Product highlightSome well-known species are the East Asian Tricholoma matsutake, also known as "matsutake" or songi, and the North American species Tricholoma magnivelare, also known as "ponderosa mushroom", "American matsutake", or "Pine mushroom". Some are good to eat, yet there are a few poisonous members, such as T. pardinum, T. tigrinum and T. equestre. Many species originally described within Tricholoma have since been moved to other genera. These include the Wood blewit (Lepista nuda), previously Tricholoma nudum, blewit (Lepista saeva), previously Tricholoma personatum, and St George's mushroom (Calocybe gambosa) previously Tricholoma gambosum. Species list
References
|
||||||||||||||||||
| This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tricholoma". A list of authors is available in Wikipedia. |
- Organische Synthese mit kleinem Volumen und hohem Durchsatz - Neue Methode zur Synthese und Bewertung einer großen Anzahl von Wirkstoff-Leads
- Merck annonce que Hiba Therapeutics est le lauréat de la bourse « North American Advance Biotech Grant » 2026 - Avec TROIKA, cette start-up basée à Boston développe une plateforme programmable d'activation des lymphocytes T destinée à lutter contre les tumeurs solides
- EXoZymes se voit attribuer une subvention de 2 millions de dollars du NIH pour faire progresser la recherche sur les analogues des cannabinoïdes dans le cadre de la découverte de nouveaux médicaments - Le montant total des financements sans effet dilutif accordés à eXoZymes s'élève désormais à près de 20 millions de dollars



